This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Schiller B, Doss S, De Cock E, del Aguila M, Nissenson A.Activity-based cost analysis of in-center anemia treatment in hemodialysis patients. American Journal of Kidney Diseases 49: 72, No. 4, Apr 2007
Hollenbeak C, Davies A, McClellan WM, de Lissovoy G.Cost-effectiveness of epoetin alfa in patients on chronic kidney dialysis. American Journal of Kidney Diseases 49: 45, No. 4, Apr 2007
Mody S, Vekeman F, Gosselin A, Bookhart B, McKenzie RS, Lefebvre P.Drug utilization and cost considerations of erythropoietic stimulating agents in chronic kidney disease patients not receiving dialysis. American Journal of Kidney Diseases 49: 61, No. 4, Apr 2007
Rights and permissions
About this article
Cite this article
News from the annual NKF meeting. Pharmacoecon. Outcomes News 529, 6 (2007). https://doi.org/10.2165/00151234-200705290-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705290-00015